Lv1
40 积分 2025-05-26 加入
Development and validation of a diagnostic nomogram in pulmonary hypertension due to left heart disease
7小时前
已完结
Tissue plasminogen activator receptor ANXA2 and its complementary regulator anti-inflammatory ANXA1 as prognostic indicators of inflammatory response in COVID-19 pathogenesis
28天前
已完结
Echocardiographic risk stratification in heart failure with post-capillary pulmonary hypertension: prognostic value of LAVI and TAPSE/PASP
2个月前
已完结
A Nomogram for Predicting 3-Year Mortality in Patients with Pulmonary Hypertension due to Left Heart Failure: A Retrospective Analysis of a Prospective Registry Study
2个月前
已完结
EP4/ANXA2 axis in pulmonary arterial hypertension: therapeutic implications
8个月前
已完结
EDIL3 regulates pulmonary artery smooth muscle cell proliferation and migration via integrin αVβ3/ERK1/2 axis in pulmonary hypertension
8个月前
已完结
Pulmonary arterial hypertension and targeting pulmonary vascular remodelling: are we there yet?
11个月前
已关闭
Pulmonary hypertension in COPD exacerbation: a transient storm with long-term consequences?
11个月前
已关闭
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbidities
11个月前
已完结
Portal vein thrombosis in a patient with COVID-19
11个月前
已完结